Inflectra

Because it costs more than Remicade or if it costs less, it's not enough to get HCP's to use it.

Nice going Pfizer!

 

Poor leadership and launch insight/execution!

 

Rename it Inflatra. Because the goals are inflated and the sales are flat.

 

Where are all the naysayers now!???

 

Like the NE Patriots - you can't stop us. you can only hope to contain us.

 

here we go with the insipid sports analogies. keep pulling the wool over your own eyes & go out their & contibute to that achievable Q2 goal. You got 6 weeks left to hit it. Good luck & may da schvartz be witchoo!

 

Right... can't beat them, cheat them.

 

Pfizer employee survey is available. How are your answers?

 

Tic....Toc....Ian's a little upset. The word is that he's not waiting until the end of the year. Big changes in leadership and across the whole group by the end of the second quarter. Great job.Thanks for coming.

 

Are you new to Pfizer? Mark all answers top 2 boxes. Makes it easier on you in the long run. Less "action plans" and follow up. Survey and time / money wasted is a joke.

 

Truest point I have ever read on CP!

 

Are you asserting that the "anonymous survey" is not truly anonymous?

 

Can't move fast enough!

 

Changes in leadership? What leadership? You must mean install leadership, because it has never existed. Pfizer is known for this.
Big talkers, no real walkers.

 

a blunder launch of epic proprtions. damned drug isn't sellable. krappy pricing and no payor access. and of course, field sales will be blamed for failure to execute a "best in class" launch strategy.

har har har!!!

 

Ouch. Are reps leaving?

 

"[After the FDA approved Samsung’s copy, Renflexis, last month, Bernstein analyst Ronny Gal wrote that with a "second biosimilar entering, we expect the market to shift to more of a land grab approach coupled with sharper price declines.”]"